Hormone Replacement Therapy Induces Breast Cancer Growth & Promotes Spreading To Other Body Parts. By Lester Mondragon | Jul 14, 2017 03:05 AM EDT Menopausal women tend to have health issues when they reach the age of having to go through the fits that all females will experience. Menopause comes to all women along with vaginal dryness, irregular periods, night sweats, hot flash episodes, mood swings, sleeping problems, slowing metabolic functions with weight increase, hair problems, and dry skin. One of the solutions that used to be recommended is Hormonal Replacement Therapy. HRT or Hormonal Replacement Therapy alleviates hormonal symptoms sufferers and prevents bone loss when in treatment. It was in 2002 that HRT was proven to have a link with breast cancer development and its spread to other parts of the body which physicians term as metastasis or stage 4 cancer. This is also the year when women indulging in HRT decreased in numbers. Despite the risk factors presenting the treatment, many women still went on with HRT. Two types of HRT treatment are available to ease the pesky hormonal imbalance symptoms. One is the infusion of the hormones estrogen and progesterone and the other is estrogen only. The first hormone combination treatment increases the risk of breast cancer development by 75 percent. The more amount of HRT combination treatment a woman receives, the more likely that breast cancer develops. The HRT combination treatment develops breast cancer within two to three years of treatment. Estrogen HRT will develop breast cancer with a minimum treatment of 10 years, reports Breast Cancer Organization. The study of these cancer cells proliferation will help scientists target these breast cancer cells and formulate immunotherapies to combat its spreading elsewhere in the body. Zalk Endowed Professor in Tumor Angiogenesis Salman Hyder and Professor of Medical Biosciences in the College of Veterinary Medicine and the Dalton Cardiovascular Center confirms that the natural and synthetic HRT methods promote breast cancer development and metastization to the lymph nodes, reports The Science Daily. Women with breast cancer on their menopause stage are given clinical advice not to indulge in Hormonal Replacement Therapy. This will induce breast cancer cell development and expedite metastasis to other parts away from the origin.